Tai Ching Ho
Keine laufenden Positionen mehr
Vermögen: 6 864 $ am 31.12.2023
Profil
Tai Ching Ho is the founder of two companies.
He founded BeiGene Ltd.
in 2010 and served as President from 2010 to 2012.
He also founded Metastagen, Inc. in 2013 and served as Chief Executive Officer from 2013 to 2014.
Dr. Ho held several former jobs, including Vice President-Oncology Development at Johnson & Johnson from 2008 to 2010, Chief Medical Officer & Executive Vice President at Epizyme, Inc. from 2015 to 2017, and Senior Vice President-Oncology Center at GlaxoSmithKline LLC.
He was also Chief Medical Officer at Boston Pharmaceuticals, Inc. from 2018 to 2020 and Independent Director at Aravive, Inc. from 2021 to 2024.
Dr. Ho received his undergraduate degree from The Johns Hopkins University and his doctorate from Yale School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARAVIVE, INC.
0,08% | 03.08.2023 | 55 353 ( 0,08% ) | 6 864 $ | 31.12.2023 |
Ehemalige bekannte Positionen von Tai Ching Ho
| Unternehmen | Position | Ende |
|---|---|---|
| ARAVIVE, INC. | Direktor/Vorstandsmitglied | 17.01.2024 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
| EPIZYME, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2017 |
Metastagen, Inc.
 Metastagen, Inc. Pharmaceuticals: MajorHealth Technology Metastagen, Inc. manufactures pharmaceutical products. The private company is based in Wilmington, DE. The company was founded by Tai Ching Ho. | Vorstandsvorsitzender | 01.09.2014 |
| BEIGENE, LTD. | Gründer | 01.12.2012 |
Ausbildung von Tai Ching Ho
| The Johns Hopkins University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BEIGENE, LTD. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Metastagen, Inc.
Metastagen, Inc. Pharmaceuticals: MajorHealth Technology Metastagen, Inc. manufactures pharmaceutical products. The private company is based in Wilmington, DE. The company was founded by Tai Ching Ho. | Health Technology |
